Business
Reuters Exclusive: Generics drugmaker Mylan NV (MYL.O), which is in the middle of a three-way takeover battle, has said it is unwilling to...
Hi, what are you looking for?
Reuters Exclusive: Generics drugmaker Mylan NV (MYL.O), which is in the middle of a three-way takeover battle, has said it is unwilling to...
John Paulson's hedge fund has increased its holdings in Mylan NV to 4.5%.
The rejection assists Teva's $41 billion bid for Mylan, which is contingent on the Perrigo deal not going ahead.